Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
recruiting133%
withdrawn133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

CW2IP2: Imaging and Diagnostic Assessments

NCT06083467
withdrawn

Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia

NCT04408391
unknownnot_applicable

Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection

NCT03393442

Clinical Trials (3)

Showing 3 of 3 trials
NCT06083467Not Applicable

CW2IP2: Imaging and Diagnostic Assessments

Recruiting
NCT04408391

Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia

Withdrawn
NCT03393442Not Applicable

Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer Detection

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3